Company Overview: Fibrocell

About the Company

Tweeter Linkedin

The Leader in Autologous Fibroblast Therapies

At the forefront of personalized biologics

Fibrocell, a cell and gene therapy company, is focused on diseases affecting the skin and connective tissue. Our approach to personalized biologics is distinctive based on our proprietary autologous fibroblast technology. By extracting fibroblast cells from a patient’s own skin, we create localized gene therapies that are compatible with the unique biology of each patient and have the potential to address the underlying cause of disease.

Investor Toolkit

Company News

Email Subscription


Follow this blog

Get every new post delivered right to your inbox.

Email address